The Unlearn Platform

Drive efficiency and precision across your clinical development with the power of AI-generated digital twins

AI-Powered Clinical Study Design

AI-Powered
Clinical Study Design

01.

Randomized Control Studies

Design smaller, faster, highly-powered randomized trials that leverage digital twins to reduce sample sizes without sacrificing power. Alternatively, use digital twins to boost trial power without adding additional trial participants. This approach is qualified by the EMA and aligns with current FDA guidance.

02.

Single-Arm Studies

Generate digital twins as a simulated control group in single-arm studies, enabling precise treatment effect analysis for the trial. This provides a robust comparator group without needing a traditional or externally matched control arm.

Predictive and Actionable Insights

01.

Leverage historical digital twin simulations

To optimize patient population, endpoints, and trial duration for an upcoming study.

02.

Explore predicted outcomes

In your ongoing trial for any participant or subgroup across key clinical variables – outcomes and biomarkers – at any point in time.

03.

Discover expected progression

As participants enroll and make more informed, data-driven decisions throughout the trial.

Precise Trial Analysis

Precise
Trial Analysis

01.

Obtain precise treatment effect estimates

For all variables at any time, for the full trial population, and in predefined subgroups.

02.

Boost statistical power for confident decision-making

Whether at interim stages or end of study. Achieve greater confidence in assessing drug effectiveness, reducing uncertainty, and enabling more informed decision-making.

03.

Discover responder subpopulations for targeted treatment

To identify likely responder individuals and subpopulations. Unlock valuable insights into the patients who benefit the most from the treatment.